Viewpoint Molecular Targeting, Inc.

New Filing
CIK: 0001768245·Biotechnology·DELAWARE·Filed: Dec 4, 2020
Total Offering

$15,847,498

Amount Sold

$8,843,739

Investors

26

First Sale

Nov 20, 2020

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Frances Johnson
Related Person
Michael Schultz
Related Person
Heyward Coleman
Related Person
Curtis Nelson
Related Person
Cameron Gray
Related Person

Company

Viewpoint Molecular Targeting, Inc.

2500 CROSSPARK ROAD E-116

CORALVILLE, IA, 52241

8653561861

SEC Filing

0001768245-20-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Viewpoint Molecular Targeting, Inc. Form D Filing — $15,847,498 | FilingFlow